Luba Greenwood

Luba Greenwood, J.D. is a prominent figure in the venture capital and biopharmaceutical sectors, currently serving as the Managing Partner of Binney Street Capital Venture Fund at Dana-Farber Cancer Institute since April 2019, where Luba founded and leads investments in therapeutics, diagnostics, and digital health. In addition to this role, Luba is a Senior Advisor to the CEO of Second Opinion Media and hosts the Second Opinion Podcast. Luba holds various leadership positions including Chief Executive Officer and Chair of the Board of Directors at Kojin Therapeutics, Lecturer in Engineering Sciences at Harvard University, and Board Member for IN8bio, while also serving on the Board of Directors for Abcam and BenchSci. Luba is actively involved with NextPoint Therapeutics, served as a Board Director for MassBio since March 2018, and is a Medical Advisor for StuffThatWorks.